Research-use context: This article is provided for laboratory research and educational purposes only. It is not medical, therapeutic, diagnostic, veterinary, dosing or human-use guidance.
A dual-receptor research molecule
Tirzepatide is a synthetic peptide investigated as an agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. For laboratory research, that receptor profile makes correct molecular identity central to interpretation.
Identity and purity answer different questions
Chromatographic purity can characterise the relative composition observed by a separation method, while mass spectrometric evidence can support molecular identity. Neither should be treated as a substitute for the other. Quantity is a separate analytical attribute again.
Batch-specific evidence
A useful research record links the supplied lot to the laboratory report, test date and analytical methods. This supports reproducibility when material from different batches is compared.
Reference
Coskun T et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist. Mol Metab. 2018;18:3-14.